Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

PreTel

PreTel
2015 FOUNDED
PRIVATE STATUS
Grant LATEST DEAL TYPE
$149K LATEST DEAL AMOUNT
5 INVESTORS
Description

Provider of monitoring and decision support solutions designed for all stages of pregnancy. The company's monitoring system identifies independent contraction activity of individual regions of the uterus and allows for improved care in the preterm labor patient, managing the progress of labor at the time of delivery and safety to the admiration of induction therapy, enabling hospitals to improve both maternal and neonatal outcomes in the labor and delivery department and avoid unnecessary C-Section deliveries, post-delivery maternal hemorrhage, and expensive neonatal intensive care nursery stays.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Monitoring Equipment
Primary Office
  • 871 McCallie Avenue
  • Chattanooga, TN 37403
  • United States

+1 (423) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore PreTel’s full profile, request a free trial.

PreTel Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Grant 01-Jan-2018 $149K 00.000 Completed Generating Revenue
4. Early Stage VC 27-Dec-2017 00000 00.000 Completed Generating Revenue
3. Early Stage VC (Series A) 15-Mar-2017 00.00 00.000 00.00 Completed Generating Revenue
2. Seed Round 08-Jan-2016 $375K $450K 00000 Completed Startup
1. Seed Round 30-Mar-2015 $74.9K $74.9K 00000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

PreTel Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A 000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Seed 2 000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Seed 115,300 $0.000100 5% $0.65 $0.65 1x $0.65 6.43%
To view this company’s complete Cap Table, request access »

PreTel Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
U.S. Department of Health and Human Services Government 000 0000 000000 0
Solas BioVentures Venture Capital Minority 000 0000 000000 0
Foley Ventures Venture Capital Minority 000 0000 000000 0
Tech Square Venture Partners Venture Capital Minority 000 0000 000000 0
University of Tennessee Research Foundation Limited Partner Minority 000 0000 000000 0

PreTel Executive Team (2)

Name Title Board
Seat
Contact
Info
Marc Finch Co-Founder & Chief Executive Officer
Roger Young MD Co-Founder, Chief Medical Officer & President

PreTel Board Members (3)

Name Representing Role Since Contact
Info
Blake Patton Tech Square Venture Partners Board Member 000 0000
David Adair MD Solas BioVentures Board Member 000 0000
Gregg Raybuck PreTel Board Member 000 0000